Literature DB >> 16558465

Hepatitis B Immunization of Athletic Trainers in NATA District IX.

J W Coorts1, T J Michael, W R Whitehill, J D Winborn.   

Abstract

OBJECTIVE: Preventive measures for transmission of bloodborne pathogens in athletic training should include hepatitis B virus (HBV) immunization of all certified athletic training staff and all student athletic trainers. Previously, no research has been undertaken to examine if athletic training programs follow these recommendations. The intent of this study was to investigate the number of certified athletic trainers (ATCs) and student athletic trainers (SATs) in the collegiate athletic training setting who have been immunized against HBV. DESIGN AND
SETTING: Surveys were sent to all four-year institutions (n=173) in the National Athletic Trainers' Association (NATA) District IX. Both certified and student athletic trainers at each institution were instructed to complete and return surveys.
SUBJECTS: Certified and student athletic trainers working in four-year colleges and universities in the states (n=7) belonging to NATA District IX. MEASUREMENTS: Returned surveys were evaluated by simple descriptive statistics for prevalence of ATC and SAT immunization. Other variables examined on surveys were how immunizations were paid for, amount of contact with bloodborne pathogens, use of protective barriers when in contact with bodily fluids, and differences in immunization practices according to athletic affiliation.
RESULTS: One hundred and six (61%) institutions returned 599 surveys. Of 375 SATs returning surveys, 189 (50%) identified themselves as immunized, while 168 of 223 (75%) ATCs claimed to be immunized.
CONCLUSIONS: According to the findings of this study, more emphasis should be placed on HBV immunization in the collegiate athletic training setting for the prevention of infection, especially with regard to SATs.

Entities:  

Year:  1997        PMID: 16558465      PMCID: PMC1320347     

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  10 in total

1.  July 6 deadline for compliance with all provisions of OSHA regs.

Authors:  L J Albrecht
Journal:  Tex Med       Date:  1992-07

2.  Prevention of hepatitis B virus infection.

Authors:  D E Henley
Journal:  Am Fam Physician       Date:  1993-03       Impact factor: 3.292

Review 3.  Epidemiology of hepatitis B.

Authors:  C N Shapiro
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

Review 4.  Prevention of hepatitis B virus infection.

Authors:  F J Mahoney; B T Burkholder; C C Matson
Journal:  Am Fam Physician       Date:  1993-03       Impact factor: 3.292

5.  Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers.

Authors:  R C Wood; K L MacDonald; K E White; C W Hedberg; M Hanson; M T Osterholm
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

6.  Hepatitis B vaccine responsiveness in Connecticut public safety personnel.

Authors:  A J Roome; S J Walsh; M L Cartter; J L Hadler
Journal:  JAMA       Date:  1993 Dec 22-29       Impact factor: 56.272

7.  Prevention of hepatitis B virus in athletic training.

Authors:  B P Buxton; J E Daniell; B H Buxton; E M Okasaki; K W Ho
Journal:  J Athl Train       Date:  1994-06       Impact factor: 2.860

Review 8.  The epidemiology of viral hepatitis in the United States.

Authors:  M J Alter; E E Mast
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

Review 9.  Therapy for hepatitis B virus infection.

Authors:  R P Perrillo; A L Mason
Journal:  Gastroenterol Clin North Am       Date:  1994-09       Impact factor: 3.806

Review 10.  Hepatitis B: evolving epidemiology and implications for control.

Authors:  H S Margolis; M J Alter; S C Hadler
Journal:  Semin Liver Dis       Date:  1991-05       Impact factor: 6.115

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.